Alab Laboratoriasp. z o.o.

Independent medical laboratory activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-09-06
Share capital
1 069 582,00 PLN
Registered address
Stępińska 22/30, 00-739 Warszawa, Poland
Electronic delivery address
AE:PL-97673-93876-WHVEG-22

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 195.27mMedianUSD 1.19mAverageUSD 20.98m
Net profit
This companyUSD 5.89mMedianUSD 101.78kAverageUSD 1.28m
Operating costs
This companyUSD 181.89mMedianUSD 1.08mAverageUSD 18.94m
Assets
This companyUSD 130.57mMedianUSD 1.07mAverageUSD 11.99m

Bank accounts

Registered as a VAT taxpayer on 2004-04-29. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Dec 13, 2021Merger registered

Public aid

PurposeGross amount
Aid for research and development projects: industrial research
—
Aid for research and development projects: experimental development
—
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—

European Funds

ProjectEU co-financing
Innowacyjne zestawy chemiczne niezbędnych do precyzyjnej detekcji oraz oznaczania poszczególnych substancji w organizmie człowieka z wykorzystaniem technologii HPLC i LCMS
$501.7K
STWORZENIE NOWOCZESNEGO CENTRUM BADAWCZEGO W CELU OPRACOWANIA INNOWACYJNYCH METOD DIAGNOSTYCZNYCH
$499.0K

Tenders

37 tenders recorded as contractor: 16 national ($637,516) and 21 EU ($18,297,862).

SubjectAmount
Integracja systemu szpitalnego AMMS z systemem LIS Marcel (ALAB)
$17,443
Badania histopatologiczne
—
KBL/2/2026 - Konkurs ofert w zakresie realizacji badań diagnostycznych – laboratoryjnych i genetycznych dla Instytutu „CZMP”
$176.7K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Ewa Małkowska — President of the Management Board
Łukasz Fraszka — Attorney-in-fact (sole)
Maciej Władysław Hipsz — Management Board Member
Tomasz Mariusz Łaszkiewicz — Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorized to represent the company independently.

Ownership

OwnerSharesShare valueStake
Hans Jakob Limbach (79)
6,810$158,200.9754.756%
Ewa Małkowska (61)
1,718$39,910.3213.8136%
Parkstreet Trading & Investments Ag
3,720$86,418.1529.9108%
Others
189$4,390.601.5196%

Beneficial owners

Person
Bogusław Tadeusz Gnatowski (74)
Hans Jakob Limbach (79)

Subsidiaries

NameStake
Teldocsp. z o.o.
24.3268%
100%
100%

Capital group

Competitors

Name
PZU ZdrowieS.A.
ScanmedS.A.
Centrum Medyczne Enel-MedS.A.
LUX Med Onkologiasp. z o.o.
Affideasp. z o.o.
Szpital Wolski Im. Dr Anny Gostyńskiejsp. z o.o.
Nutrimedsp. z o.o.
Centrum Medyczne Damiana Holdingsp. z o.o.
Szpital Czerniakowskisp. z o.o.
Szpital Grochowski Im.Dr Med. Rafała Masztakasp. z o.o.

Change history

DateEvent
2021-08-25Share capital change
2010-02-22Address change
2008-12-12Share capital change
2008-09-08Share capital change
2008-03-25Address change

FAQ

Last updated: 2026-09-16